Human equilibrative nucleoside transporter 1 (hENT1) in gemcitabine and FOLFOX (oxaliplatin, 5-fluorouracil, and leucovorin)-treated patients with metastatic pancreatic cancer: The randomized phase II PAN1 study.
暂无分享，去创建一个
V. Gebski | J. Mackey | D. Goldstein | C. Karapetis | K. Sjoquist | Y. Chua | S. Begbie | E. Abdi | Cheryl Santos | C. Underhill | D. Ferraro | L. Nott | R. O’Connell | N. Wong | M. Hall | M. Cronk | T. V. Hagen